BackTscan Therapeutics Overview

Tscan Therapeutics Total Revenue

Revenue analysis for TCRX.

Quarterly Revenue

$982000.00
54.77% YoY

As of Mar 2026

Annual Revenue (TTM)

$6.63M
49.85% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading